MolNFT v1 · #148008 · protein
The fibrinogen-like domain of human ANGPTL3
6EUA · Angiopoietin-related protein 3: “The fibrinogen-like domain of human ANGPTL3”. X-ray diffraction, 3 pockets (best druggability 0.72). MolNFT v1 #148008 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6EUA
- Type
- protein
- Length
- 601 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Angiopoietin-related protein 3
- UniProt
- Q9Y5C1
- Pockets
- 3 · best druggability 0.72
Structure
x-ray diffraction · 3 distinct chains · 13% helix, 40% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Angiopoietin-related protein 3 | protein | 202 | 13% helix, 41% strand | Q9Y5C1 |
| B | Angiopoietin-related protein 3 | protein | 201 | 13% helix, 40% strand | Q9Y5C1 |
| C | Angiopoietin-related protein 3 | protein | 198 | 13% helix, 39% strand | Q9Y5C1 |
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 880 | 0.72 | 0.77 | 113 | empty |
| 2 | 558 | 0.70 | 0.79 | 42 | empty |
| 3 | 54 | 0.30 | 0.76 | 12 | empty |
Interfaces
3 interfaces between chains.
- A–C · 533 Ų buried · 10 hydrogen bonds · protein-protein
- A–B · 533 Ų buried · 8 hydrogen bonds · protein-protein
- B–C · 499 Ų buried · 5 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 6 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9Y5C1
- Elsewhere: RCSB PDB 6EUA · PDBe 6EUA · UniProt Q9Y5C1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.